Skip to main content

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Back to top

OPKO Health to Report Second-Quarter 2026 Financial Results on July 27 and Host Conference Call

OPKO Health will report Q2 2026 results on July 27, with a conference call scheduled for 4:30 p.m. ET.

Quiver AI Summary

OPKO Health, Inc. announced that it will report its operating and financial results for the second quarter of 2026 on July 27, 2026. The company's senior management will host a conference call and webcast at 4:30 p.m. ET to discuss the business update, financial results, and guidance. Participants are encouraged to pre-register for the call to receive a unique PIN for easier access. Those unable to pre-register can join via specified phone numbers. A replay of the call will be available until August 3, 2026, as well as a webcast replay shortly after the live event. OPKO is focused on next-generation healthcare solutions and aims to lead in rapidly growing markets through its innovative technologies.

Potential Positives

  • OPKO Health is set to report its second-quarter 2026 operating and financial results, which could indicate growth and progress in their operations.
  • The scheduled conference call and webcast provide an opportunity for transparency, allowing stakeholders to gain insights directly from senior management.
  • The inclusion of both U.S. and international participation options for the conference call broadens accessibility for investors globally, potentially enhancing investor relations.
  • OPKO emphasizes its commitment to next-generation healthcare solutions, aligning with industry trends towards innovative healthcare advancements.

Potential Negatives

  • Announcement of financial results may indicate ongoing uncertainty or lack of progress, potentially raising concerns among investors regarding the company's financial health.
  • Pre-registration for the conference call suggests that the company anticipates high interest or potential scrutiny from stakeholders, which could imply that recent performance has been under question.
  • No specific achievements or positive developments were highlighted in the press release, which may lead to skepticism about the company's recent performance or strategic direction.

FAQ

When will OPKO Health report its financial results for Q2 2026?

OPKO Health will report its financial results on July 27, 2026.

How can I participate in the OPKO conference call?

You can participate by pre-registering or calling 833-630-0584 (U.S.) or 412-317-1815 (International).

Where can I find the webcast of the OPKO conference call?

The webcast can be accessed through OPKO’s Investor Relations page.

Is there a replay available for the OPKO conference call?

Yes, a telephone replay will be available until August 3, 2026, and a webcast replay will be accessible one hour after the live call.

What does OPKO Health focus on?

OPKO Health is focused on delivering next-generation solutions for serious diseases across established global markets.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.


EARLY ACCESS
Receive OPK Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$OPK Insider Trading Activity

OPK Insider Trades

$OPK insiders have traded $OPK stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $OPK stock by insiders over the last 6 months:

  • JOHN A PAGANELLI purchased 10,000 shares for an estimated $11,350

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$OPK Hedge Fund Activity

We have seen 82 institutional investors add shares of $OPK stock to their portfolio, and 79 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • GOLDMAN SACHS GROUP INC added 1,688,113 shares (+28.2%) to their portfolio in Q1 2026, for an estimated $1,924,448
  • BLACKROCK, INC. added 1,380,193 shares (+4.0%) to their portfolio in Q1 2026, for an estimated $1,573,420
  • AQR CAPITAL MANAGEMENT LLC removed 1,263,367 shares (-62.3%) from their portfolio in Q1 2026, for an estimated $1,440,238
  • OP ASSET MANAGEMENT LTD added 1,102,254 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,256,569
  • CITADEL ADVISORS LLC removed 777,886 shares (-27.2%) from their portfolio in Q1 2026, for an estimated $886,790
  • UBS GROUP AG added 718,648 shares (+13.4%) to their portfolio in Q1 2026, for an estimated $819,258
  • JANE STREET GROUP, LLC removed 660,961 shares (-37.2%) from their portfolio in Q1 2026, for an estimated $753,495

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Full Release

MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.

CONFERENCE CALL & WEBCAST INFORMATION

OPKO encourages participants to pre-register for the conference call using this link . Participants who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed through OPKO’s Investor Relations here .

A telephone replay will be available until August 3, 2026, by dialing 855-669-9658 (U.S.) or 412-317-0088 (International) and providing the passcode 6858214. A webcast replay will be available beginning approximately one hour after the completion of the live conference call through OPKO’s Investor Relations here .

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com .

Contacts:

Alliance Advisors IR
Vivian Cervantes, 973-873-7724
vcervantes@allianceadvisors.com


Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

OPKO Health, Inc. (OPK)